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In Brief
Nagelberg et al. show that the progenitors for the arteries of the heart arise from a small population of mesodermal cells, which require the transcription factors Tcf21 and Nkx2.5 for their specification. In the absence of these cells, the heart arteries are formed by other endothelial cells, pointing to an unexpected vascular plasticity.
INTRODUCTION
During vascular development, endothelial cells invade the pharyngeal arches to form the arteries that will connect the heart to the dorsal aorta and establish the circulatory system of the embryo [1] . In mammals, the posterior pharyngeal arch arteries 3-6 (pPAAs) are subsequently remodeled to form the great vessels-the carotid arteries, the aortic arch, and the pulmonary arteries [2, 3] -and improper formation of the great vessels results in cardiac birth defects in humans [4] . Fate mapping studies in fish and mice indicate that cells in the secondary heart field contribute to the head and heart muscles and the endothelium of the pharyngeal arch arteries. In mice, clonal analysis suggests that distinct progenitor pools give rise to distinct portions of head and heart muscles [5] [6] [7] . In mice and fish, nkx2.5-expressing mesoderm gives rise to heart muscle as well as pPAA endothelium [8] . Together, these observations suggest that the head muscles, the heart, and the pharyngeal arch arteries share a common origin. This idea is also supported by overlapping gene expression patterns and genetic requirements in these head structures; several transcription factors and signaling molecules are co-expressed in head muscles, the heart, and the pharyngeal arch arteries [9, 10] , and some of these are required in the progenitors of all three tissues to promote correct head muscle, heart, and pharyngeal arch artery formation [11] [12] [13] [14] . Similarly, the co-occurrence of craniofacial and cardiac birth defects also supports the idea of a shared origin of head structures and the heart [4, 15, 16] . For example, key features of the DiGeorge Syndrome are cardiac abnormalities, abnormal facies, and a cleft palate [17] . Together, these studies suggest that the pharyngeal arch arteries are derived from a large mesodermal population that also gives rise to head and heart muscle (reviewed in [18] ). However, despite these observations, the exact origin of the pPAAs, the mechanism of their specification, and their regenerative potential remain unclear.
Here, we show that the pPAA progenitors arise from a small population of head mesodermal cells that co-express the cardiac marker nkx2.5 and the head myoblast marker tcf21. Consistent with this expression profile, we find that the pPAA progenitors also require the transcription factors nkx2.5 and tcf21 for their specification. However, in the absence of the pPAA progenitors, the pPAAs still form. We find that this surprising vascular plasticity is possible due to neighboring endothelial cells that migrate in and replace the missing pPAAs.
RESULTS
tcf21+ Cells Contribute to Head Muscles, the Ventral Head Vasculature, and the Heart To understand the role of the pharyngeal mesoderm in pPAA development, we sought a genetic marker to visualize and manipulate this tissue [19] . Consistent with observations in chicken and mice [20] [21] [22] , we find that the transcription factor tcf21 (Epicardin/Capsulin/Pod1) is expressed bilaterally at the 12-somite stage (15 hours postfertilization, hpf) in two domains within the head mesoderm-an anterior domain and a posterior domain ( Figure 1A ). Using tcf21:mCherry-NTR (referred to as tcf21:mCherry if not indicated otherwise), a transcriptional reporter for tcf21+ cells [23] , we find that at the 14-somite stage (16 hpf), the anterior tcf21 expression domain is bounded anteriorly by the prechordal plate mesoderm marked by pitx2 White squares in (D) and (E) indicate region shown with increased intensity to demonstrate domain overlap in insets in (D) and (E). sox10:GFP was used to mark the neural crest contribution to the pharyngeal arches. Arrows in insets indicate region where tcf21 and nkx2.5 are co-expressed. n = 5 for (D) and (E); n = 1 for (F); n = 5 for (G); n = 2 for (H); n = 1 for (I). (J) Staining of pitx2 mRNA and mCherry protein in a 15-somite stage embryo (n = 13). (K) Schematic summary of pitx2, tcf21, and nkx2.5 expression in the head mesoderm in the 14-somite stage embryo. Note that in this study, the term ''head mesoderm'' refers to the mesoderm comprised of the prechordal plate mesoderm, the pharyngeal mesoderm, and the cardiac mesoderm. Pitx2, tcf21, and nkx2.5 mark-possibly only parts of-the prechordal plate, pharyngeal mesoderm, and pharyngeal mesoderm/secondary heart field mesoderm, respectively. [24] and overlaps posteriorly with the cardiac mesoderm marked by a transcriptional reporter for nkx2.5 (nkx2.5: ZsYellow) [8, 25] (Figures 1D, 1J , and 1K). The posterior domain of tcf21 expression overlaps anteriorly with the nkx2.5-expressing domain (Figures 1D and 1E ; Movie S3). During the next day, tcf21 expression refines to the cores of the pharyngeal arches, where it is surrounded by neural crest cells, and splits into dorsal and ventral clusters, which then divide further into smaller clusters ( Figures 1G-1I) . Later, mCherry from the tcf21:mCherry transgene labels most of the head muscles ( Figures 1L, 1M , and 4A-4D) as suggested previously [20-22, 26, 27] . However, mCherry also labels some of the dorsal and most of the ventral head vasculature, including part of the lateral dorsal aorta (LDA), the hypobranchial arteries (HAs), the pPAAs, and parts of the ventral aorta (VA) ( Figures 1N, 1O , 4Q-4T, and 5A-5D). As this part of the head vasculature does not express tcf21 once formed, it is likely labeled by mCherry protein that perdures in the descendants of tcf21+ cells. Together, this indicates that tcf21 marks two populations of the head mesoderm and suggests that these two cell populations give rise to part of the muscles and vasculature of the head. To test this idea, we followed the fate of tcf21+ cells using Cre-mediated fate mapping. We generated embryos that express tamoxifen-inducible CreERT2 recombinase from the tcf21 promoter (tcf21:CreERT2) [27] and carry the bactin2:RSG indicator line (bactin2:loxP-DsRed-STOP-loxP-EGFP), which switches from RFP to GFP expression after excision of the loxP-flanked RFP sequence [28] . We incubated these double transgenic embryos with 4-hydroxytamoxifen (4-HT) from 9 to 24 hpf and scored for the presence of GFP clones at 4.5 days postfertilization (dpf) (Figure 2A ). Consistent with the labeling of the muscles and the vasculature of the head by mCherry protein perdurance from the tcf21:mCherry transgene ( Figures 1L-1O ), this protocol labeled cells with GFP in pharyngeal arch-derived head muscles, in the endothelial cells of pPAAs 3-6, the HA, and the VA, as well as tissues in the cardiac outflow tract and ventricle ( Figures 2B-2E ). This corroborates the idea that tcf21+ cells give rise not only to part of the head muscles but also to the ventral head vasculature.
tcf21+ Cells Are Required for Head Muscle Formation but Not for PAA Formation Our finding that most of the muscles and ventral vasculature of the head are derived from tcf21+ progenitors suggests that tcf21+ cells should be required for formation of these tissues. To determine whether this prediction holds true, we analyzed embryos expressing a codon-optimized version of the bacterial enzyme nitroreductase (NTRo) from the tcf21 promoter (tcf21:mCherry-NTR) [23] . NTR converts the non-toxic prodrug metronidazole (Mtz) to a cytotoxic, DNA-crosslinking agent. The NTR-Mtz system has been used successfully to ablate specific cell types in zebrafish larvae [30, 31] . We bathed tcf21:mCherry-NTR embryos in Mtz from 9 hpf to 48 hpf (Figure 3A) and found in most embryos that tcf21+ cells, labeled in red by the tcf21:mCherry-NTR transgene, died between 36 hpf to 38 hpf ( Figure S1A ). No dying cells were observed in DMSOtreated tcf21:mCherry-NTR embryos or Mtz-treated non-transgenic embryos. Using this approach, we ablated tcf21+ cells in tcf21:mCherry-NTR embryos also carrying the muscle-specific a-actin:GFP transgene. In such embryos, all pharyngeal archderived head muscles were lost while the eye and neck musculature was not affected ( Figures 3B-3I, 3D 0 , 3E 0 , 3H 0 , and 3I 0 ), and the cartilage was deformed but correctly patterned ( Figures  S1B-S1E ). This is consistent with previous fate mapping studies which place the origin of the eye muscles in the prechordal plate mesoderm [32] [33] [34] and the origin of the neck muscles mostly in the somitic mesoderm [5, 35] . In stark contrast to the complete ablation of the pharyngeal head muscles, the ventral head vasculature was only slightly impaired in Mtz-treated tcf21: mCherry-NTR embryos at 5 dpf. Mtz-treated tcf21:mCherry-NTR embryos carrying the endothelium-specific flk:GFP transgene form the LDA, the VA, and all pPAAs ( Figures 3J-3Q, 3L 0 , 3M 0 , 3P 0 , and 3Q 0 ). By contrast, the HA is mostly missing and always fails to connect to the LDA ( Figures 3N-3Q, 3P 0 , and 3Q 0 ; Table S1 ).
The failure to ablate the ventral head vasculature is not due to the failure to ablate the tcf21+ cells because fluorescent protein (E) Summary of tcf21+ cell contributions to different tissues in wild-type embryos and in tcf21 mutant embryos assessed by live confocal microscopy (wt embryos, n = 95; tcf21À/À embryos n = 34). Scale bars represent 100 mm (B and C) and 10 mm (D). Anterior is to the left. Ventral views. From left to right: PA1, pharyngeal arch 1-derived skeletal muscle; PA2, pharyngeal arch 2-derived skeletal muscle; PA 3-6, skeletal muscle derived from PAs 3-6; pPAAs, pharyngeal arch arteries 3-6; HA, hypobranchial artery; VA, ventral aorta; other, other vascular labeling; OFT, outflow tract (myocardium, endothelium, smooth muscle, or epicardium); VM, ventricle (myocardium, endothelium, smooth muscle, or epicardium); other, cells derived from tcf21-expressing progenitors that we cannot unambiguously assign to a specific tissue. 0 , 3U 0 , 3X 0 , 3Y 0 , respectively). Moreover, following tcf21+ cells in individual tcf21:mCherry-NTR embryos that co-express the endothelial marker flt1:YFP indicates that tcf21+ cells are completely ablated at 2 dpf but that the pPAAs show few or no defects by 5 dpf (Figures S1F-S1M ). This indicates that most of the ventral head vasculature is able to form without its progenitors, most likely explained by an alternate cell population that compensates for the lost ventral head vasculature progenitors.
Tcf21 Is Required for Head Muscle Formation and Together with Nkx2.5 for Head Vasculature Formation
To determine whether tcf21 itself is required for the formation of the head muscles and the ventral head endothelium, we generated a tcf21 deletion mutant ( Figure S2A ). In tcf21 mutant embryos, all head muscles with the exception of the eye and neck-homologous muscles are either missing or severely reduced. Some fibers of the intermandibularis anterior, the interhyoideii, and the most posterior head muscles are frequently still present (Figures 4A-4H, 4C 0 , 4D 0 , 4G 0 , and 4H 0 ), while heart morphology and function do not show a discernible defect (Figures S2B , S2E, and S2H) and the cartilage is only mildly affected ( Figures S2C, S2D , S2F, and S2G). Time-lapse microscopy shows that tcf21+ cells are born in tcf21 mutant embryos and initiate their migration into the pharyngeal arches. However, these cells begin to die around 26 hpf, such that by 60 hpf, few tcf21+ muscle progenitors remain (Movie S1). This indicates that Tcf21 is not required for the initial specification and migration of tcf21+ cells into the pharyngeal arches but rather for the survival of head muscle progenitors. These observations are consistent with findings in mice and flies where Tcf21 promotes-in mice together with its paralog musculin/MyoR-the specification and survival of progenitors for a subset of jaw muscles and longitudinal gut muscles, respectively [22, 36] . In contrast to the clear requirement for tcf21 in the head muscles, the ventral head vasculature is only mildly affected in tcf21 mutant embryos. While the hypobranchial artery often fails to connect completely or is misshapen, all pharyngeal arch arteries form and become eventually lumenized ( Figures 4Q-4X, 4S 0 , 4T 0 , 4W 0 , 4X 0 , and 5R; Table S2 ). Since tcf21+ cells contribute to both head muscle and head endothelium but only the head muscles require Tcf21 activity, it is likely that Tcf21 acts together with another transcription factor to promote specification and/or survival of tcf21+ endothelial cells. One candidate for such a transcription factor is Nkx2.5, as a subset of the tcf21+ cells co-express nkx2.5 before mesoderm migration into the pharyngeal arches ( Figures 1D and 1E) . Moreover, nkx2.5-expressing (nkx2.5+) cells also contribute to the pPAAs [8] , and perduring fluorescent proteins expressed from the tcf21 and nkx2.5 promoters co-label the ventral head endothelium ( Figures 1L, 1M, 5A-5D, and 5D 0 ). To test this idea, we analyzed the formation of the ventral head endothelium in tcf21 mutant, nkx2.5 mutant, and tcf21;nkx2.5 double mutant embryos transgenic for flk:mCherry to label endothelial cells and nkx2.5:ZsYellow to label pPAA progenitors. In contrast to nkx2.5 morpholino knockdown experiments [8] , which have recently been reported to be error prone [37] , we find that the pPAAs are present at 60 hpf in tcf21 mutant, nkx2.5 mutant, and tcf21;nkx2.5 double mutant embryos, although pPAAs occasionally failed to lumenize in nkx2.5 mutant, tcf21 mutant, and tcf21;nkx2.5 double mutant embryos ( Figure 5R Figures 3J-3Q, 3L 0 , 3M 0 , 3P 0 , and 3Q 0 ) suggests that tcf21 and nkx2.5 might be required for pPAA progenitor formation but dispensable for other cells to compensate in pPAA formation. To address this possibility, we asked whether pPAA progenitors are specified, survive, and contribute to the pPAAs in tcf21;nkx2.5 double mutant embryos. To assess specification, we tested whether pPAA progenitors initiate the expression of the endothelial differentiation marker tie1 in tcf21:mCherry transgenic embryos [38, 39] . Although we find that a subset of the tcf21+ cells express tie1 in the pharyngeal arches at 36 hpf in all four genotypes-wild-type, tcf21 mutant, nkx2.5 mutant, and tcf21;nkx2.5 double mutants-its expression is mostly absent from pharyngeal arches 3 and 4 and weaker in the pharyngeal arches 5 and 6 in tcf21;nkx2.5 double mutant embryos compared to wild-type and tcf21 or nkx2.5 single mutant embryos ( Figure S3 and see file ImageJscripts3.ijm in Data S1). This suggests that the pPAA progenitors are not fully specified in the absence of Tcf21 and Nkx2.5 activity.
To test for survival of pPAA progenitors, we followed tcf21; nkx2.5 co-expressing cells in tcf21:mCherry-NTR and nkx2.5:ZsYellow double transgenic embryos by time-lapse microscopy. Such embryos have three differently labeled fluorescent cell populations: nkx2.5+-only cells, tcf21+-only cells, and nkx2.5+; tcf21+ cells. To follow these three cell populations separately, we segmented the movies based on the fluorescence intensities of the tcf21:mCherry-NTR and nkx2.5:ZsYellow transgenes and assigned each cell population a pseudo color using a custom-written ImageJ script (see file ImageJscripts1.ijm in Data S1). This analysis shows that nkx2.5+; tcf21+ pPAA progenitor cells die between 40 and 42 hpf in tcf21;nkx2.5 double mutant embryos, but not in wild-type, tcf21 mutant, or nkx2.5 mutant embryos (Movie S2), suggesting that the failure in proper specification compromises the survival of pPAA progenitors 4-6 hr later.
We assessed the contribution of pPAA progenitors to the pPAAs in wild-type, tcf21 mutant, nkx2.5 mutant, and tcf21; nkx2.5 double mutant embryos in two transgenic backgrounds: in the first, we used flk:mCherry as a marker for the pPAAs and nkx2.5:ZsYellow as a marker for the pPAA progenitors. In the second, we used flk:GFP as a marker for the pPAAs and tcf21:mCherry as a marker for the pPAA progenitors. Similar to what we see in wild-type embryos, we find that in nkx2.5 mutant embryos, almost all pPAAs express ZsYellow from the nkx2.5 promoter or mCherry from the tcf21 promoter and are derived from pPAA progenitors ( Figures 5A-5H, 5D 0 , 5H 0 , and 5Q; Figure S2I; see file ImageJscripts2.ijm in Data S1). Also, the pPAAs in tcf21 mutant embryos are mostly composed of nkx2.5+ and tcf21+ pPAA progenitors, although some embryos occasionally display a pPAA that is only partly composed of pPAA progenitors ( Figures 5I-5L , 5Q, and S2I). In contrast, the pPAAs in tcf21;nkx2.5 double mutant embryos are mostly devoid of pPAA progenitor cells, displaying a small contribution of nkx2.5+ and tcf21+ cells, if any, to the pPAAs ( Figures 5M-5P, 5Q, and S2I) . Similarly, the nkx2.5+ and tcf21+ HA progenitors are absent in tcf21; nkx2.5 double mutant embryos. However, in contrast to the pPAAs that form in the absence of pPAA progenitors, the HA recovers only partly and never connects to the LDA in the absence of its progenitors (Figures 5O and 5P; Table S2 ). This suggests that in contrast to the pharyngeal head muscle progenitors, which require only Tcf21 activity for their formation, the pPAA and HA progenitors require the combined activity of Tcf21 and Nkx2.5 for their specification and survival, a requirement that is masked in the pPAAs by compensation by other cells in the absence of the pPAA progenitors.
The Pharyngeal Arch Arteries Are Derived from the Interface between the Pharyngeal and Cardiac Mesoderm
To locate more precisely where pPAA progenitors are born, we used time-lapse microscopy to follow nkx2.5+/tcf21+ cells in the head mesoderm from the 15-somite stage (16.5 hpf) to 44 hpf (Movie S3). Consistent with our expression analysis (Figure 1) , nkx2.5+ cells are flanked anteriorly and posteriorly by tcf21+ cells, and cells at the borders between the expression domains co-express both transcription factors at the 15-somite stage. Thus, the expression of tcf21 and nkx2.5 delineate three different cell populations in the head mesoderm: tcf21+ cells, nkx2.5+ cells, and tcf21+/nkx2.5+ cells.
We followed these three cell populations separately by segmenting the movies based on the fluorescence intensities of the tcf21:mCherry-NTR and nkx2.5:ZsYellow transgenes and pseudo-coloring each cell population as described above (see ImageJscripts1.ijm in Data S1). This analysis shows that a few nkx2.5+ cells move medially to contribute to the heart while others move laterally and ventrally to form the pericardial sac. In contrast, the cells in the two tcf21+ domains move anteriorly with the cells in the posterior tcf21 expression domain moving faster, such that by 24 hpf, the posterior cells almost reach the anterior cells and bridge the initial gap that was created by the nkx2.5+-only cells. During this migration toward the anterior, the tcf21+ and tcf21+/nkx2.5+ cells coalesce into individual clusters that then form the inner cores of the pharyngeal arches. The cells in the anterior tcf21 expression domain contribute to the core of the first and second pharyngeal arch, while the cells in the posterior tcf21 expression domain contribute to the posterior five pharyngeal arches and then form dorsal head muscles and part of the LDA. The tcf21/ nkx2.5 co-expressing cells from the borders between the nkx2.5 and tcf21 expression domains also move anteriorly, similar to the tcf21+ cells. However, in contrast to the tcf21+ cells, which populate the dorsal part of the inner core of the pharyngeal arches, the tcf21+/nkx2.5+ cells move to the ventral part of the pharyngeal arches and ultimately form ventral head muscles and the HA, the pPAAs, and the VA. These observations indicate that the progenitors of the ventral head vasculature, including the pPAA progenitors, originate from the anterior and posterior borders of the nkx2.5 expression domain, where it overlaps with the tcf21 expression domain.
Dorsal Head Endothelial Cells Compensate for the Loss of Pharyngeal Arch Artery Progenitors
Although pPAA progenitors are lost in embryos with ablated tcf21+ cells and in tcf21À/À; nkx2.5À/À double mutant embryos, the pPAAs still form. To determine the cellular origin for this vascular plasticity, we reasoned that a likely source of the compensating cells in embryos with lost pPAA progenitors is other, nearby endothelial cells. To test this idea, we followed endothelial cells marked by flk:GFP or flt1:YFP in Mtz-treated non-tcf21:mCherry-NTR and tcf21:mCherry-NTR embryos. In wild-type embryos, the tcf21+/nkx2.5+ pPAA progenitors migrate dorsally to connect with the LDA (Figures 6A and 6B ; Movies S3 and S4). By contrast, in embryos with ablated pPAA progenitors, endothelial cells from either the LDA or the primary head sinus migrate in the opposite direction ventrally to fill in the missing pPAAs (Figures 6C and 6D ; Movie S4). Co-staining for the pharyngeal endoderm shows that the compensating endothelial cells populate the same position in the pharyngeal arches in tcf21+ cell-ablated embryos as the pPAAs in control embryos (Movie S5). This suggests that the dorsal head vasculature is the source for the compensating cells. To confirm this observation, we generated embryos that express the photoconvertible Kaede protein in a mosaic fashion in all endothelial cells. For this, we injected UAS-Kaede DNA into cdh5:Gal4FF transgenic embryos [40] . cdh5 is a pan-endothelial marker [41] , and Kaede protein changes its fluorescence after exposure to UV light from green to red [42] . We imaged these embryos at 48 hpf before and after photoconversion of a region of cells in the dorsal head vasculature using a 405-nm laser. We then allowed the embryos to develop for 24 hr and imaged the embryos again at 72 hpf to determine the position of the photoconverted cells ( Figure 6E ). Consistent with our time-lapse analysis, we find that in embryos with ablated pPAA progenitors, photoconverted red endothelial cells from the LDA and primary head sinus move ventrally to form the pPAAs (Figures 6F-6I ). By contrast, photoconverted red endothelial cells from the LDA and primary head sinus do not move ventrally to contribute to the pPAAs in embryos in which the pPAA progenitors were not ablated ( Figures 6J-6M) . As in embryos with ablated pPAA progenitors, endothelial cells from the LDA and primary head sinus also restore the pPAAs in tcf21À/À; nkx2.5À/À double mutants, in which the pPAA progenitors fail to specify properly and die; time-lapse analysis of embryos carrying the endothelial marker flk:mCherry and the pPAA progenitor marker nkx2.5:ZsYellow shows that endothelial cells from the dorsal head vasculature sprout and migrate ventrally from the dorsal head vasculature to form the pPAAs ( Figures 6O, 6Q , and 6S; Movie S6). In contrast, in wild-type control embryos, the pPAAs are formed by the nkx2.5+ pPAA progenitors ( Figures 6N, 6P , and 6R; Movie S6). In tcf21 mutant embryos, endothelial cells from the dorsal head vasculature occasionally contributed to the pPAAs, consistent with the observation that the pPAA progenitors are occasionally reduced in number in this genetic scenario ( Figures 5I, 5J, and 5Q) . Together, these observations indicate that the dorsal head vasculature is the source for the plasticity of the pPAAs in scenarios where the pPAA progenitors are absent.
DISCUSSION
Our results suggest a model in which tcf21+, tcf21+/nkx2.5+, and nkx2.5+ mesoderm give rise to head muscles, much of the ventral head vasculature, and the heart (Figure 7) . According to this model, the pharyngeal head muscle progenitors are born in the two domains of the tcf21+ mesoderm that abut the nkx2.5+ heart mesoderm at its anterior and posterior borders. The anterior and posterior borders of the heart mesoderm, where cells express both tcf21 and nkx2.5, give rise to the progenitors of much of the ventral head vasculature and the ventral pharyngeal head muscles, with cells at the anterior border giving rise to the HA and cells at the posterior border forming the pPAAs. During pharyngeal arch formation, the nkx2.5+ cells stream medially and laterally to contribute to the heart and the tissues of the pericardium, respectively, while the tcf21+/nkx2.5+ vascular and muscle progenitors at the anterior and posterior borders move closer to each other and populate the ventral cores of the pharyngeal arches-the dorsal cores are populated by tcf21+ head muscle progenitors. These morphogenetic movements bring the progenitors of the HA and pPAAs, respectively, anterior and dorsal to the forming heart and provide a cellular explanation for the co-occurrence of many craniofacial and cardiac birth defects [4, 15, 16] .
The related cellular origins of the head muscles, ventral head vasculature, and part of the heart are also reflected on a molecular level. Our and others' genetic analyses show that the tcf21+ pharyngeal head muscle progenitors require Tcf21 activity for their specification [22, 26] . Similarly, we find that the tcf21+/ nkx2.5+ vascular HA and pPAA progenitors require the joint activity of Tcf21 and Nkx2.5 for their specification, and previous studies have shown that Nkx2.5 is required for ventricular identity in the heart [43] [44] [45] [46] . Together, these observations suggest that the different combinations of these two transcription factors divide the head mesoderm into three domains that give rise to three spatially and molecularly related structures: (1) the pharyngeal head muscles, (2) the HA and the pPAAs, and (3) part of the heart (Figure 7 ). This not only adds a molecular explanation to the cellular explanation for the co-occurrence of many craniofacial and cardiac birth defects [4] but also points to the molecular machinery that may be necessary to make pPAA progenitor cells in vitro.
Intriguingly, we find that embryos with ablated ventral head vascular progenitors remake their posterior pPAAs from endothelial cells in the dorsal head vasculature. The compensating blood vessels in embryos with ablated pPAAs invade the pharyngeal arches up to a day later and from the opposite direction than the developing pPAAs in wild-type embryos, suggesting that the molecular mechanism underlying this plasticity is distinct from the guidance program in wild-type embryos. In principle, there are several possible scenarios for how compensating endothelial cells are recruited to re-form the lost pPAAs. Dying pPAA progenitors could secrete an endothelial attractant that then recruits nearby endothelial cells. However, given the 24-hr time span over which the pPAAs are re-formed, it is also likely that the dying pPAA progenitors activate adjacent cells to express an endothelial attractant to recruit compensating endothelial cells. Alternatively, the wild-type PAAs could physically block dorsal endothelial cells from moving in, such that when the wild-type PAAs are lost, dorsal endothelial cells are unbounded and able to migrate in to form the missing arteries. More generally, this vascular plasticity allows the embryo to correct for minor defects in pPAA development to sustain proper circulation. Since congenital heart defects affect almost 1% of births per year in the United States [47, 48] , the heart and its associated great vessels seem to be especially vulnerable to genetic and traumatic perturbation, suggesting that such a vascular buffering capacity might be essential. Moreover, if this plasticity proves to be a broader theme in development and maintenance of the vasculature, it might explain why many genes expressed in endothelial cells do not seem to be essential [37] and may warrant a closer phenotypic analysis.
EXPERIMENTAL PROCEDURES Zebrafish Strains
Embryos were staged as previously described [29] . tcf21 D236 (this study) and Mtz/NTRo-Mediated Cell Ablation For tcf21+-cell ablation, tcf21:mCherryNTRo embryos were bathed in embryo water containing 10 mM Mtz (Sigma, M1547) as previously described [49] from 9 hpf to 48 hpf-or in the case of movies beginning before 48 hpf, 9 hpf to 36hpf-and transferred to embryo water without Mtz until the embryos were analyzed or until 5 dpf. Live embryos were mounted in agar, and z stacks were collected on a Leica SP5 II confocal microscope. ImageJ (NIH) was used to create maximum projections of the z stacks.
Cre-Mediated Fate Mapping For 4-hydroxytamoxifen (4-HT, Sigma Aldrich) labeling, 9 hpf tcf21:Cre-ER; bactin2:RSG embryos were placed in embryo medium with 4-HT added to a final concentration of 5 mM, from a 1 mM stock solution made in 100% ethanol. After 15 hr, embryos were washed and placed in embryo medium without 4-HT until the embryos were 4.5 dpf. Live embryos were mounted in agar, z stacks were collected on a Leica SP5 II confocal microscope and genotyped for the tcf21 mutation. GFP-labeled cells were manually scored by visual inspection using ImageJ (NIH). Embryos with putative GFP-labeled muscle fibers and endothelial cells were fixed and co-stained for MHC and Cdh5, respectively, to confirm the identity of the GFP-labeled cells. . nkx2.5+/tcf21+ cells (green) are found at the interface of the nkx2.5+ and tcf21+ domains, where these two domains overlap. Anterior tcf21+ and nkx2.5+/tcf21+ populations will give rise to the mesodermal cores of pharyngeal arches (PAs) 1 and 2, while posterior tcf21+ and nkx2.5+/tcf21+ populations will form the mesodermal cores of PAs 3-7. nkx2.5+/tcf21+ cells from the anterior domain will give rise mostly to the ventral head muscles derived from PAs 1-2 and the hypobranchial artery (HA), while nkx2.5+/tcf21+ cells from the posterior domain will give rise mostly to the ventral head muscles derived from PAs 3-7 and the posterior pharyngeal arch arteries 3-6 (pPAAs). tcf21+ cells from the anterior domain will give rise to dorsal and some ventral head muscles from PAs 1-2, while tcf21+ cells from the posterior domain will give rise to dorsal and some ventral head muscles from PAs 3-7. nkx2.5+ cells will give rise to the heart and pericardium. Dorsal view. 
